泛生子取得甲基化标志物位点及脑干胶质瘤分型预后模型专利

Core Viewpoint - Beijing PanGene Biotechnology Co., Ltd. has obtained a patent for a methylation marker site, brainstem glioma classification, and prognosis model, indicating advancements in cancer diagnostics and treatment [1] Group 1 - The patent is titled "A Methylation Marker Site, Brainstem Glioma Classification and Prognosis Model" [1] - The patent authorization announcement number is CN120060477B [1] - The application date for the patent was April 2025 [1]